編號 | 商品編號 | 商品名稱 | 作者 | 類別 | 使用課程名稱 |
1 | 9-201-023 | Merck & Co.: Evaluating a Drug Licensing Opportunity | Ruback, Richard S.;Krieger, David | Finance | advanced Corporate Finance( BF322 ) |
2 | 9-276-195 | Communications Satellite Corp. | Mullins, David W., Jr. | Finance | advanced Corporate Finance( BF322 ) |
3 | 9-282-043 | Massey-Ferguson Ltd.--1980 | Baldwin, Carliss Y.;Mason, Scott P.;Hughes, Jennifer H. | Finance | advanced Corporate Finance( BF322 ) |
4 | 9-289-012 | Colt Industries | Stein, Jeremy C. | Finance | advanced Corporate Finance( BF322 ) |
5 | 9-289-047 | Marriott Corp.: The Cost of Capital (Abridged) | Ruback, Richard S. | Finance | advanced Corporate Finance( BF322 ) |
6 | 9-289-056 | RJR Nabisco | Ruback, Richard S. | Finance | advanced Corporate Finance( BF322 ) |
7 | 9-292-140 | Arundel Partners: The Sequel Project | Luehrman, Timothy A.;Teichner, William A. | Finance | advanced Corporate Finance( BF322 ) |
8 | 9-295-047 | Tiffany & Co.--1993 | Kester, W. Carl;Backstrand, Kendall | Finance | advanced Corporate Finance( BF322 ) |
9 | 9-101-019 | Vyaderm Pharmaceuticals: The EVA Decision | Simons, Robert;Reinbergs, Indra A. | Other | advanced Corporate Finance( BF322 ) |
10 | 9-112-034 | Super Project | Vancil, Richard F.;Wyman, Harold E. | Other | advanced Corporate Finance( BF322 ) |